Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 1800 (LINC01800) is a large non-coding RNA transcribed from intergenic regions, meaning it does not overlap protein-coding genes. LINC01800 is part of the lincRNA family; lincRNAs are typically over 200 nucleotides in length and have limited or no coding capacity for proteins[1]. LincRNAs often participate in gene regulation, influence chromatin state, or affect transcriptional activity, sometimes modulating expression of nearby or distant genes[3][5]. While some lincRNAs have disease or functional roles, there is currently no specific information on the biological function, disease relevance, drug interaction, or biomarker utility for LINC01800. As with many lincRNAs, further research is required to determine its specific molecular and functional significance.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 1800 (LINC01800).